摘要近年来的研究表明，细胞免疫是机体抗肿瘤免疫的主要方式，而T淋巴细胞及其亚群是细胞免疫主要功能细胞，在一定程度上可反映患者的免疫状态。为了解肺癌患者机体免疫状态、免疫功能情况，探讨细胞免疫在肺癌患者发病过程中的作用。本文用流式细胞仪对43例肺癌患者DNT（double negative T cells）细胞及T淋巴细胞亚群进行了检测分析，现报告如下。
1D'Acquisto F, Crompton T. CD3 + CD4 - CD8 - ( double negative) T cells:saviours or villains of the iannune response? [ J]. Biochem Phar- macol,2011,82(4) :333-340.
2Feyler S,von Lilienfeld-Toal M, Jarmin S, et al. CD4 ( + ) CD25 ( + ) FoxP3 ( + ) regulatory T cells are increased whilst CD3 ( + ) CIM ( - )CD8 ( - )alphabetaTCR( + ) Double Negative T ceils are decreased in the peripheral blood of patients with multiple myeloma which correlates with disease burden[J]. Br J Haematol,2009,144(5) :686-695.
3Hamakawa T,Kurekawa Y, Takiguchi S ,et al. Combination chemo- therapy using docetaxel, cisplatin, and s-1 for far advanced gastric cancer [ J]. Gan To Kagaku Ryoho,2011,38(12) :2342-2344.
4Gill RS,A1-Adra DP, Nagendran J, et al. Treatment of gastric canc- er with peritoneal careinomatosis by cytoreduetive surgery and H/PEG : a systematic review of survival, mortality, and morbidity [ J ]. J Surg Oncol, 2011,104(6) :692-698.
4Poleri C, Morero JL, Nieva B, et al. Risk of recurrence in patients with surgically resected stage I non-small cell lung carcinoma: his- topathologic and immunohistochemical analysis[]]. Chest, 2003, 123 (6):1858-1867.
5Huang M, Stolina M. Sharma S, et al. Non-small cell lung cancer cyclooxygenase-2-dependent regulation of cytokine balance ill lymphocytes and macrophages: up---regulation of interleukin 10 and down-regulation of interleukin 12 production[J]. Cancer Res, 1998, 58(6):1208-1216.
6Grivennikov SI, Greten FR, Karin M. Immunity, inflanamation, and cancer[J]. Cell, 2010, 140(6):883-899.
7SunJC, BeilkeJN, Lanier LL. Adaptive immune features of natural killer cells[J]. Nature, 2009, 457(7229):557-561.
8Hamakawa T, Kurokawa Y, Takiguchi S, et al. Combination che- motherapy using docetaxel, cisplatin, and S-1 for far advanced gas- tric cancer[J]. Gan To Kagaku Ryoho, 2011, 38(12):2342-2344.
9Jde CosJS, Miravet L, AbalJ, et al. Lung cancer survival in Spain and prognostic factors: a prospective, multiregional study[J]. Lung Cancer, 2008, 59(2):246-254.
10Nakamura HI, Sail H, Ogata A, et al. Immunologic parameters as significant prognostic factors in lung cancer[J]. Lung Cancer, 2002, 37(2):161-169.
